Suggested Topics within your search.
Suggested Topics within your search.
- Child 7
- Infant 7
- methods 5
- Critical Care 4
- Emergencies 3
- Physical Examination 3
- Children 2
- Diagnosis 2
- Diseases 2
- Emergency Treatment 2
- Medical examinations 2
- Pediatric Nursing 2
- Pediatric emergencies 2
- Anesthesia 1
- Cardiac Surgical Procedures 1
- Care 1
- Child development 1
- Child rearing 1
- Congresses 1
- Critical Illness 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
- English 1
- Handbooks, manuals, etc 1
- Heart Defects, Congenital 1
- Infant Nutrition Disorders 1
- Infants 1
- Medical History Taking 1
- Medicine 1
-
1761
Design and validation of a questionnaire on habits, health and exercise in the use of baby carriers
Published 2025-01-01“…It extracted 3 factors each for the constructs of duration and weight of carriage, motivation, exercise habits and effects on infant health and 2 factors for caregiver pain that explained between 55% and 72% of the variance in each construct. …”
Get full text
Article -
1762
Conocimientos, práctica y actitudes hacia la salud oral entre matronas de España
Published 2025-07-01“…Conclusions: Midwives had moderate knowledge about oral health during pregnancy and in infants, which improved significantly after the educational intervention. …”
Get full text
Article -
1763
Maternal and neonatal complications of pregnant women with bipolar disorder: a systematic review and meta-analysisResearch in context
Published 2025-01-01“…Their newborns also appear to be at high risks of very prematurity OR = 1.84 (95% CI [1.32–2.57]; I2 = 74%), infant death OR = 1.77 (95% CI [1.01–3.13]; I2 = 41%), low birth weight OR = 1.54 (95% CI [1.19–1.99]; I2 = 70%), preterm birth OR = 1.49 (95% CI [1.29–1.72]; I2 = 87%), small for gestational age OR = 1.28 (95% CI [1.14–1.45]; I2 = 57%), and congenital malformations OR = 1.29 (95% CI [1.09–1.53]; I2 = 42%). …”
Get full text
Article -
1764
Should the Food and Drug Administration Limit Placebo-Controlled Trials?
Published 2022-07-01“…For example, in 2001, the FDA initially responded positively to a placebo-controlled trial of Surfaxin in infants with acute respiratory distress syndrome in Latin America. …”
Get full text
Article